SCHEMBL5366233

SCHEMBL5366233

c1ccc(-c2cccc3cc4ccc5cc6ccccc6cc5c4cc23)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.46
SMN1; SMN2 Q16637 6/20 0.46
LMNA P02545 5/20 0.46
TP53 P04637 4/20 0.46
CCR1 P32246 3/20 0.46
CCR5 P51681 3/20 0.46
CCR8 P51685 3/20 0.46
MAPK1 P28482 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
ALPL P05186 1/20 0.46
HSP90AA1 P07900 1/20 0.46
ALPI P09923 1/20 0.46
ALPG P10696 1/20 0.46
ALOX15 P16050 1/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HTR2C P28335 1/20 0.44
ALDH1A1 P00352 6/20 0.43
NPC1 O15118 4/20 0.43
HSD17B10 Q99714 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28681737 0.98 KDM4E (0.47) KDM4ESMN1; SMN2LMNATP53CCR1
SCHEMBL31261515 0.95 KDM4E (0.50) KDM4ESMN1; SMN2LMNATP53CCR1
SCHEMBL1817511 0.95 KDM4E (0.50) KDM4ESMN1; SMN2LMNATP53CCR1
Hydrochloric Acid SCHEMBL28716572 0.93 KDM4E (0.48) KDM4ESMN1; SMN2LMNATP53CCR1
SCHEMBL12626761 0.93 KDM4E (0.52) KDM4ESMN1; SMN2LMNATP53CCR1
SCHEMBL27845489 0.90 HTR2C (0.47) KDM4ESMN1; SMN2LMNATP53CCR1
SCHEMBL28374091 0.87 KDM4E (0.60) KDM4ESMN1; SMN2LMNATP53CCR1
SCHEMBL31290750 0.83 ALDH1A1 (0.44) KDM4ESMN1; SMN2LMNATP53CCR1
SCHEMBL6679713 0.83 CCR1 (0.46) KDM4ESMN1; SMN2LMNATP53CCR1
SCHEMBL27908766 0.82 KDM4E (0.44) KDM4ESMN1; SMN2LMNATP53CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9520570-B2 Organic electronic device and method for the production thereof OSRAM OLED GMBH (DE) 2016-12-13 US disclosed
US-9520570-B2 Organic electronic device and method for the production thereof OSRAM OLED GMBH (DE) 2016-12-13 US disclosed
EP-2483945-B1 ORGANIC ELECTRONIC DEVICE AND METHOD FOR THE PRODUCTION THEREOF OSRAM OLED GMBH (DE) 2016-11-02 EP disclosed
EP-2342772-B1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR THE PRODUCTION THEREOF OSRAM OLED GMBH (DE) 2015-12-02 EP disclosed
US-8558223-B2 Organic electronic component and method for the production thereof OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2013-10-15 US disclosed
US-8558223-B2 Organic electronic component and method for the production thereof OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2013-10-15 US disclosed
US-20120286253-A1 Organic Electronic Device and Method for the Production Thereof OSRAM OLED GMBH (DE) 2012-11-15 US disclosed
US-20120286253-A1 Organic Electronic Device and Method for the Production Thereof OSRAM OLED GMBH (DE) 2012-11-15 US disclosed
US-20110253991-A1 ORGANIC ELECTROLUMINESCENCE DEVICE NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-10-20 US disclosed
US-20110253991-A1 ORGANIC ELECTROLUMINESCENCE DEVICE NIPPON STEEL CHEMICAL CO., LTD. (JP) 2011-10-20 US disclosed
EP-2378584-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Pioneer Corporation (JP) 2011-10-19 EP disclosed
WO-2011039323-A2 ORGANIC ELECTRONIC DEVICE AND METHOD FOR THE PRODUCTION THEREOF OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2011-04-07 WO disclosed
WO-2010034304-A2 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR THE PRODUCTION THEREOF OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2010-04-01 WO disclosed
US-7271266-B2 Substituted 2,3-diphenyl pyridines MERCK & CO., INC. (US) 2007-09-18 US disclosed
US-20050182103-A1 Substituted 2,3-diphenyl pyridines MERCK SHARP & DOHME CORP. 2005-08-18 US disclosed
EP-1492784-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES Merck & Co., Inc. (US) 2005-01-05 EP disclosed
WO-2003082191-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES MERCK & CO., INC. (US) 2003-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182103-A1 Substituted 2,3-diphenyl pyridines CNR1, CNR2, MAG KDM4E 1804/4885SMN1; SMN2 874/4885LMNA 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.